FAQ: Annovis Bio's Presentation at H.C. Wainwright Global Investment Conference

What is the main announcement in this content?

Annovis Bio Inc. (NYSE: ANVS) announced that CEO Maria Maccecchini, Ph.D., will present at the H.C. Wainwright 27th Annual Global Investment Conference taking place September 8-10, 2025.

Who is presenting for Annovis Bio at the conference?

Maria Maccecchini, Ph.D., the CEO of Annovis Bio, will be presenting at the conference.

When and where is the H.C. Wainwright Global Investment Conference taking place?

The conference is scheduled for September 8-10, 2025, at the Lotte New York Palace Hotel in New York City.

What is Annovis Bio’s focus and mission?

Annovis Bio is dedicated to addressing neurodegeneration in diseases such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD), developing innovative therapies to improve patient outcomes and quality of life.

Where is Annovis Bio headquartered?

Annovis Bio is headquartered in Malvern, Pennsylvania.

How can investors access the full press release?

The full press release can be viewed at https://ibn.fm/bX1aJ.

Where can I find the latest news and updates about Annovis Bio?

The latest news and updates relating to ANVS are available in the company’s newsroom at https://ibn.fm/ANVS.

What social media platforms does Annovis Bio use?

Annovis Bio maintains a presence on LinkedIn, YouTube, and X (formerly Twitter).

Who published this content and what is their role?

This content was published by InvestorWire, a specialized communications platform that provides wire-grade press release syndication and corporate communications solutions for private and public companies.